Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo clinic patients

New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera

(2015) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management

(2015) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort

(2015) Omur Gokmen Sevindik et al.   Clinical Lymphoma Myeloma & Leukemia

Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice

(2015) Ayalew Tefferi et al.   MAYO CLINIC PROCEEDINGS

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

(2015) T Barbui et al.   Blood Cancer Journal

Myeloproliferative Neoplasms

(2015) Ayalew Tefferi et al.   JAMA Oncology

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

(2014) A. Tefferi et al.   BLOOD

External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients

(2014) Rongfeng Fu et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

(2012) T. Barbui et al.   BLOOD

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

(2011) A. Carobbio et al.   BLOOD

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

(2010) A. Alvarez-Larran et al.   BLOOD